Clinical trial
Analgesic Efficacy of Magnesium Sulphate as an Adjuvant to Levo-bupivacine in Ultrasound Guided Erector Spinae Plan Block for Modified Radical Mastectomy
NCT04732364 is registered in ClinicalTrials.gov with South Egypt Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analgesic Efficacy of Magnesium Sulphate as an Adjuvant to Levo-bupivacine in Ultrasound Guided Erector Spinae Plan Block for Modified Radical Mastectomy
- Lead sponsor
- South Egypt Cancer Institute
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- April 30, 2018
- Completion date
- February 28, 2021
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pain, postoperative